TG Therapeutics Inc vs Vipshop Holdings Ltd - ADR — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Vipshop Holdings Ltd - ADR trades at $14.63 (market cap $7.01B). The key difference: TG Therapeutics Inc is the larger of the two by market cap, and Vipshop Holdings Ltd - ADR pays a 4.25% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | VIPS | |
|---|---|---|
Market Cap | $8.26B | $7.01B |
Sector | Health | Consumer Cyclical |
52-Week High | $59.06 | $20.68 |
52-Week Low | $26.39 | $12.92 |
Enterprise Value | $8.50B | $3.60B |
Dividend Yield | — | 4.25% |
Trailing returns across standard periods
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →